Linear Growth Faltering Among HIV-Exposed Uninfected Children.

J Acquir Immune Defic Syndr

*Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA; †TransMedics, Andover, MA; ‡Botswana Ministry of Health, Division of Nutrition and Food Control, Gaborone, Botswana; §Department of Neonatology, Elizabeth Glaser Pediatric AIDS Foundation, Masero, Lesotho; ‖Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA; ¶Holtz Children's Hospital, University of Miami, Miami, FL; #Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Departments of **Internal Medicine; and ††Pediatrics, Massachusetts General Hospital, Boston, MA.

Published: October 2016

Background: HIV-exposed uninfected (HEU) children experience increased mortality compared with their HIV-unexposed uninfected (HUU) peers. It is unclear whether HEU children are also at increased risk for undernutrition, a modifiable risk factor for mortality.

Methods: We conducted a cross-sectional, population-based survey of children <5 years of age in 5 health districts in Botswana. Linear mixed-effects models were used to assess continuous outcomes, and generalized estimating equations were used to estimate relative risks of stunting, wasting, and underweight between HEU (n = 396) and HUU (n = 1109) children. Secondary analyses examined potential mediation by low birth weight.

Results: The association between maternal HIV exposure and child stunting varied significantly by child age (P < 0.01). HEU children <1 and ≥2 years of age had 1.85 [95% confidence interval (CI): 1.03 to 3.31; P = 0.04] and 1.41 (95% CI: 1.06 to 1.88; P = 0.02) times the risk of stunting compared with HUU children after multivariate adjustment, respectively. During the period of 1-2 years of age, when breastfeeding cessation occurred among HUU children, HUU children had increased risk of stunting compared with HEU children who were predominantly formula fed (relative risk: 1.56; 95% CI: 1.05 to 2.32; P = 0.03). A mediation analysis estimated that 67% of the excess risk of stunting among HEU children ≥2 years was attributable to low birth weight (P = 0.02). There was no difference in risk of wasting or underweight.

Conclusion: HEU children are at increased risk of stunting compared with their HUU peers; however, interventions to increase birth weight may significantly ameliorate this excess risk. Interventions to support optimal growth during weaning are needed for all breast-fed children.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023451PMC
http://dx.doi.org/10.1097/QAI.0000000000001034DOI Listing

Publication Analysis

Top Keywords

hiv-exposed uninfected
8
heu children
8
linear growth
4
growth faltering
4
faltering hiv-exposed
4
children
4
uninfected children
4
children background
4
background hiv-exposed
4
uninfected heu
4

Similar Publications

Objective: To compare arterial stiffness between young adults with perinatally acquired HIV (YAPHIV) and young adults perinatally HIV exposed but uninfected (YAPHEU).

Design: Cross-sectional analysis of pulse wave velocity (PWV) measures among participants with echocardiography in the PHACS Cardiac Toxicity Substudy.

Methods: A total of 150 participants (95 YAPHIV, 55 YAPHEU, mean 23.

View Article and Find Full Text PDF

There is little research on anemia and vitamin D deficiency in HIV-exposed uninfected (HEU) children. This study was aimed to describe and compare the prevalence of anemia and vitamin D inadequacy in HEU children and HIV-unexposed uninfected (HUU) children, and to examine the associations of HIV exposure with anemia and vitamin D inadequacy. This was a hospital-based descriptive cross-sectional study nested within the Prevention of Mother-to-Child Transmission (PMTCT) of HIV program in Hunan Province during July and September 2022.

View Article and Find Full Text PDF
Article Synopsis
  • Children who are HIV-exposed but uninfected (CHEU) have historically shown higher morbidity and mortality rates compared to children who are unexposed (CHUU), prompting a study to assess this in the context of modern antiretroviral therapy.
  • The study involved tracking mother-infant pairs for two years in Nairobi, collecting data on illnesses, hospital visits, and feeding practices, focusing on the risks associated with various health outcomes between CHEU and CHUU infants.
  • Results indicated that while overall morbidity and mortality rates for CHEU were similar to CHUU, CHEU infants had a significantly lower risk of respiratory tract infections (RTI) and pneumonia.
View Article and Find Full Text PDF

Background: Most infants born to women living with HIV (WLH) are HIV-exposed but uninfected exposed infants have poorer growth than HIV-unexposed uninfected children. Few large studies have compared children who are exposed (CHEU) and unexposed (CHUU) in the era of dolutegravir (DTG)-based antiretroviral treatment (ART).

Setting: Longitudinal study of mother-infant CHEU and CHUU pairs in Nairobi and Western Kenya.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the safety and immunogenicity of a TdaP vaccine for pregnant women living with HIV, aiming to protect infants from severe pertussis disease.
  • Conducted in Uganda, the trial randomly assigned 181 women (HIV-positive and HIV-negative) to receive either the TdaP or Td vaccine, evaluating immune responses in infants post-delivery.
  • Findings will provide valuable insights into the vaccine's effectiveness and safety for this specific population, contributing to better health outcomes for mothers and their babies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!